Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs

被引:3
作者
Yatomi, Masakiyo [1 ]
Takazawa, Tomonori [2 ]
Yanagisawa, Kunio [3 ]
Kanamoto, Masafumi [2 ]
Matsui, Yusuke [2 ]
Tsukagoshi, Hiroyuki [4 ]
Saruki, Nobuhiro [4 ]
Saito, Shigeru [2 ]
Tokue, Yutaka [3 ]
Maeno, Toshitaka [1 ]
机构
[1] Gunma Univ Hosp, Integrat Ctr Internal Med, Dept Allergy & Resp Med, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan
[2] Gunma Univ Hosp, Intens Care Unit, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan
[3] Gunma Univ Hosp, Infect Control & Prevent Ctr, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan
[4] Gunma Prefectural Inst Publ Hlth & Environm Sci, 378 Kamioki Machi, Maebashi, Gunma 3710052, Japan
关键词
CORONAVIRUS;
D O I
10.1155/2020/8814249
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. However, after administration of another antiviral drug, remdesivir, we were able to terminate invasive interventions, including ECMO, and subsequently obtained negative polymerase chain reaction results. Although further validation is needed, remdesivir might be effective in treating COVID-19.
引用
收藏
页数:4
相关论文
共 13 条
  • [1] Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
  • [2] Gilead Sciences I t, 2020, IND ACC INV MED INT
  • [3] Compassionate Use of Remdesivir for Patients with Severe Covid-19
    Grein, J.
    Ohmagari, N.
    Shin, D.
    Diaz, G.
    Asperges, E.
    Castagna, A.
    Feldt, T.
    Green, G.
    Green, M. L.
    Lescure, F-X
    Nicastri, E.
    Oda, R.
    Yo, K.
    Quiros-Roldan, E.
    Studemeister, A.
    Redinski, J.
    Ahmed, S.
    Bernett, J.
    Chelliah, D.
    Chen, D.
    Chihara, S.
    Cohen, S. H.
    Cunningham, J.
    Monforte, A. DArminio
    Ismail, S.
    Kato, H.
    Lapadula, G.
    L'Her, E.
    Maeno, T.
    Majumder, S.
    Massari, M.
    Mora-Rillo, M.
    Mutoh, Y.
    Nguyen, D.
    Verweij, E.
    Zoufaly, A.
    Osinusi, A. O.
    DeZure, A.
    Zhao, Y.
    Zhong, L.
    Chokkalingam, A.
    Elboudwarej, E.
    Telep, L.
    Timbs, L.
    Henne, I
    Sellers, S.
    Cao, H.
    Tan, S. K.
    Winterbourne, L.
    Desai, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) : 2327 - 2336
  • [4] First Case of 2019 Novel Coronavirus in the United States
    Holshue, Michelle L.
    DeBolt, Chas
    Lindquist, Scott
    Lofy, Kathy H.
    Wiesman, John
    Bruce, Hollianne
    Spitters, Christopher
    Ericson, Keith
    Wilkerson, Sara
    Tural, Ahmet
    Diaz, George
    Cohn, Amanda
    Fox, LeAnne
    Patel, Anita
    Gerber, Susan I.
    Kim, Lindsay
    Tong, Suxiang
    Lu, Xiaoyan
    Lindstrom, Steve
    Pallansch, Mark A.
    Weldon, William C.
    Biggs, Holly M.
    Uyeki, Timothy M.
    Pillai, Satish K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) : 929 - 936
  • [5] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30211-7, 10.1016/S0140-6736(20)30183-5]
  • [6] Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
    Li, Guangdi
    De Clercq, Erik
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 149 - 150
  • [7] A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
    Mulangu, Sabue
    Dodd, Lori E.
    Davey, Richard T., Jr.
    Mbaya, Olivier Tshiani
    Proschan, Michael
    Mukadi, Daniel
    Manzo, Mariano Lusakibanza
    Nzolo, Didier
    Oloma, Antoine Tshomba
    Ibanda, Augustin
    Ali, Rosine
    Coulibaly, Sinare
    Levine, Adam C.
    Grais, Rebecca
    Diaz, Janet
    Lane, H. Clifford
    Muyembe-Tamfum, Jean-Jacques
    Sivahera, Billy
    Camara, Modet
    Kojan, Richard
    Walker, Robert
    Dighero-Kemp, Bonnie
    Cao, Huyen
    Mukumbayi, Philippe
    Mbala-Kingebeni, Placide
    Ahuka, Steve
    Albert, Sarah
    Bonnett, Tyler
    Crozier, Ian
    Duvenhage, Michael
    Proffitt, Calvin
    Teitelbaum, Marc
    Moench, Thomas
    Aboulhab, Jamila
    Barrett, Kevin
    Cahill, Kelly
    Cone, Katherine
    Eckes, Risa
    Hensley, Lisa
    Herpin, Betsey
    Higgs, Elizabeth
    Ledgerwood, Julie
    Pierson, Jerome
    Smolskis, Mary
    Sow, Ydrissa
    Tierney, John
    Sivapalasingam, Sumathi
    Holman, Wendy
    Gettinger, Nikki
    Vallee, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (24) : 2293 - 2303
  • [8] NIH, 2020, NIH Clinical Trial of Remdesivir to Treat COVID-19 Begins
  • [9] Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan
    Shirato, Kazuya
    Nao, Naganori
    Katano, Harutaka
    Takayama, Ikuyo
    Saito, Shinji
    Kato, Fumihiro
    Katoh, Hiroshi
    Sakata, Masafumi
    Nakatsu, Yuichiro
    Mori, Yoshio
    Kageyama, Tsutomu
    Matsuyama, Shutoku
    Takeda, Makoto
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2020, 73 (04) : 304 - 307
  • [10] Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
    Wang, Dawei
    Hu, Bo
    Hu, Chang
    Zhu, Fangfang
    Liu, Xing
    Zhang, Jing
    Wang, Binbin
    Xiang, Hui
    Cheng, Zhenshun
    Xiong, Yong
    Zhao, Yan
    Li, Yirong
    Wang, Xinghuan
    Peng, Zhiyong
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11): : 1061 - 1069